AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental injection targets tough blood cancers and anemia
Disease control Recruiting nowThis early-stage study tests a new treatment called GT801 in 28 adults with certain blood cancers (like leukemia and lymphoma) or an autoimmune blood disorder (AIHA) that have not responded to standard therapies. The treatment uses specially modified cells to target a protein cal…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
Massive blood disease registry launches in china
Knowledge-focused Recruiting nowThis study is creating a large database of people in China with various blood diseases, such as leukemia, multiple myeloma, and hemophilia. Researchers will collect information from medical records and follow participants over time to learn about disease patterns, treatments, and…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC